• EU issues full approval for AZ’ Tagrisso pharmatimes
    April 27, 2017
    European regulators have now issued a full approval for AstraZeneca’s lung cancer drug Tagrisso, having awarded the drug a conditional approval in February last year.
  • FDA hands over full approval to AZ’ Tagrisso pharmatimes
    April 07, 2017
    US regulators have issued a full approval for AstraZeneca’s lung cancer drug Tagrisso on the back of a strong progression-free survival (PFS) benefit observed in a late-stage trial.
PharmaSources Customer Service